Olema Pharmaceuticals, Inc. (OLMA)
9.82
-0.08
(-0.81%)
USD |
NASDAQ |
Sep 18, 16:00
9.82
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Price to Book Value : 1.994 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.994 |
| September 17, 2026 | 2.011 |
| September 16, 2026 | 1.976 |
| September 15, 2026 | 1.986 |
| September 14, 2026 | 2.09 |
| September 11, 2026 | 2.076 |
| September 10, 2026 | 2.171 |
| September 09, 2026 | 2.104 |
| September 08, 2026 | 2.231 |
| September 04, 2026 | 2.183 |
| September 03, 2026 | 2.179 |
| September 02, 2026 | 2.200 |
| September 01, 2026 | 2.145 |
| August 31, 2026 | 2.118 |
| August 28, 2026 | 2.086 |
| August 27, 2026 | 2.192 |
| August 26, 2026 | 2.204 |
| August 25, 2026 | 2.216 |
| August 24, 2026 | 2.118 |
| August 21, 2026 | 2.171 |
| August 20, 2026 | 2.214 |
| August 19, 2026 | 2.297 |
| August 18, 2026 | 2.163 |
| August 17, 2026 | 2.188 |
| August 14, 2026 | 2.159 |
| Date | Value |
|---|---|
| August 13, 2026 | 2.135 |
| August 12, 2026 | 2.120 |
| August 11, 2026 | 2.118 |
| August 10, 2026 | 2.425 |
| August 07, 2026 | 2.448 |
| August 06, 2026 | 2.397 |
| August 05, 2026 | 2.352 |
| August 04, 2026 | 2.389 |
| August 03, 2026 | 2.291 |
| July 31, 2026 | 2.326 |
| July 30, 2026 | 2.401 |
| July 29, 2026 | 2.273 |
| July 28, 2026 | 2.360 |
| July 27, 2026 | 2.439 |
| July 24, 2026 | 2.376 |
| July 23, 2026 | 2.384 |
| July 22, 2026 | 2.334 |
| July 21, 2026 | 2.354 |
| July 20, 2026 | 2.305 |
| July 17, 2026 | 2.330 |
| July 16, 2026 | 2.248 |
| July 15, 2026 | 2.401 |
| July 14, 2026 | 2.407 |
| July 13, 2026 | 2.407 |
| July 10, 2026 | 2.419 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| SELLAS Life Sciences Group, Inc. | 16.85 |
| ACADIA Pharmaceuticals, Inc. | 3.595 |
| Alnylam Pharmaceuticals, Inc. | 23.66 |
| Anika Therapeutics, Inc. | 2.029 |
| Savara, Inc. | 7.678 |
Price to Book Value Related Metrics
| PEG Ratio | -0.4565 |
| Price | 9.82 |
| Earnings Yield | -21.57% |
| Market Cap | 858.78M |
| PEGY Ratio | -0.4565 |